Search company, investor...

Biotech Acquisition

Founded Year

2021

Stage

IPO | IPO

Date of IPO

1/26/2021

Market Cap

0.29B

Stock Price

10.04

About Biotech Acquisition

Biotech Acquisition (NASDAQ: BIOTU) is a blank check company, also commonly referred to as a Special Purpose Acquisition Company, or SPAC, formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities.

Headquarters Location

545 West 25th Street 20th Floor

New York, New York, 10001,

United States

212-227-1905

Missing: Biotech Acquisition's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Biotech Acquisition's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest Biotech Acquisition News

Sterling Biotech Acquisition To Double Production Capacity In Near Term: Perfect Day

Nov 30, 2022

Perfect Day has received an approval from the FSSAI for its animal-free milk proteins, making way for commercialisation in India. 6:57 PM IST, 30 Nov 2022 6:57 PM IST, 30 Nov 2022 6:57 PM IST, 30 Nov 2022 Save ADVERTISEMENT The U.S.-based food technology startup Perfect Day Inc. on Wednesday said the acquisition of Sterling Biotech will enable the firm to scale up the production of animal-free milk proteins to cater to both domestic and export markets. The U.S.-based food technology startup Perfect Day Inc. on Wednesday said the acquisition of Sterling Biotech will enable the firm to scale up the production of animal-free milk proteins to cater to both domestic and export markets. The company, founded in 2014 by Ryan Pandya and Perumal Gandhi, has received an approval from the Food Safety and Standards Authority of India for its animal-free milk proteins, opening the door for commercialisation in India. In the near-term, Perfect Day will export animal-free protein produced in India to meet increasing global customer demands while it works on building a roadmap for domestic commercial opportunities. In a statement issued on Wednesday, the company noted that the acquisition of Sterling Biotech will double its production capability in the near-term with the addition of four high-value assets, including two operational manufacturing facilities in Masar, Gujarat—more than returning on the company's immediate investment of 1.5 times the winning auction price of Rs 638 crore, it added. These manufacturing facilities include precision fermentation capabilities with existing fermenters that will allow the company to expand its precision fermentation capabilities in the months ahead while continuing to service existing SBL customers in both the pharma and protein sectors, the Berkeley-based firm said. "This strategic acquisition stands to vastly expand our ability to make and sell protein while leveraging our robust technology platform across new ingredient opportunities," Perfect Day CEO and Co-founder Ryan Pandya stated. He further said: "Our mission is one driven by collaboration, and we look forward to working closely with Sterling Biotech's existing customers and employees as we continue to expand our investment in India and drive positive change together." Perfect Day emerged as the successful bidder for acquiring Gujarat-based Sterling Biotech Ltd. through the liquidation process. ADVERTISEMENT

Biotech Acquisition Frequently Asked Questions (FAQ)

  • When was Biotech Acquisition founded?

    Biotech Acquisition was founded in 2021.

  • Where is Biotech Acquisition's headquarters?

    Biotech Acquisition's headquarters is located at 545 West 25th Street, New York.

  • What is Biotech Acquisition's latest funding round?

    Biotech Acquisition's latest funding round is IPO.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.